Cyclodextrin-based nanosponge co-delivery of doxorubicin and EMD: synergistic anticancer activity with improved selectivity toward cancer cells
Combination therapy has emerged as a promising strategy in cancer treatment, aiming to enhance therapeutic efficacy and overcome drug resistance.
